InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,408.75
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.81
(
-0.11%
)
Bitcoin
65,747.67
(
-1.11%
)
Post# of 252232
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: masterlongevity post# 146499

Friday, 08/03/2012 6:55:15 AM

Friday, August 03, 2012 6:55:15 AM

Post# of 252232
One more point is that in the failed phase 3 carriers trial, only the lower 0.5mg/kg dose was used, while both the 0.5 and the 1mg/kg were used in the non-carriers trial, so perhaps a bit better chance for the drug to show efficacy. Would like to see the biomarkers data and the mild subgroup, maybe there was a trend there.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up